Abstract
Background: Frontal fibrosing alopecia (FFA) has become one of the most common causes of cicatricial alopecia worldwide. However, there is a lack of clear aetiology and robust clinical trial evidence for the efficacy and safety of agents currently used for treatment. Objectives: To enable data to be collected worldwide on FFA using common criteria and assessment methods. Methods: A multicentre, international group of experts in hair loss was convened by email to create consensus recommendations for clinical trials. Consensus was defined at > 90% agreement on each recommended part of these guidelines. Results: Standardized diagnostic criteria, severity rating, staging, and investigator and patient assessment of scalp hair loss and other clinical features of FFA were created. Conclusions: These guidelines should allow the collection of reliable aggregate data on FFA and advance efforts in both clinical and basic research to close knowledge gaps in this condition.
Original language | English (US) |
---|---|
Pages (from-to) | 1221-1231 |
Number of pages | 11 |
Journal | British Journal of Dermatology |
Volume | 185 |
Issue number | 6 |
Early online date | Jun 9 2021 |
DOIs | |
State | Published - Aug 13 2021 |
Bibliographical note
Funding Information:sources Duke University Hair Research Fund and the Foundation for the Advancement of Hair Disorders.
Publisher Copyright:
© 2021 British Association of Dermatologists